Dr Reddys Laboratories (RDY) Accounts Payables (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Accounts Payables of $356.0 million for Q1 2026, down 14.63% year-over-year from $417.0 million in Q1 2025, and down 14.63% quarter-over-quarter from $417.0 million in Q1 2025.
Dr Reddys Laboratories (RDY) Accounts Payables (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Accounts Payables history runs 18 years deep, the most recent figure standing at $356.0 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 14.63% year-over-year to $356.0 million; the TTM figure through Mar 2026 stood at $356.0 million (down 14.63% YoY), while the FY2026 annual figure was $356.0 million, down 14.63% from the prior year.
- Accounts Payables for Q1 2026 stood at $356.0 million, down from $417.0 million in the prior quarter.
- The five-year high for Accounts Payables was $417.0 million in Q1 2025, with the low at $305.0 million in Q2 2022.
- The 5-year median for Accounts Payables is $337.0 million (2022), against an average of $349.3 million.
- The sharpest annual moves came in 2024 and 2026: Accounts Payables climbed 15.22% in 2024, then declined 14.63% in 2026.
- Dr Reddys Laboratories' Accounts Payables stood at $305.0 million in 2022, then gained by 10.49% to $337.0 million in 2023, then grew by 10.09% to $371.0 million in 2024, then grew by 12.4% to $417.0 million in 2025, then fell by 14.63% to $356.0 million in 2026.
- Business Quant data shows RDY's Accounts Payables at $356.0 million in Q1 2026, $417.0 million in Q1 2025, and $371.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 332.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 356.00 Mn |
| Mar 31, 2025 | 417.00 Mn |
| Mar 31, 2024 | 371.00 Mn |
| Jun 30, 2023 | 337.00 Mn |
| Mar 31, 2023 | 322.00 Mn |
| Jun 30, 2022 | 305.00 Mn |
| Mar 31, 2022 | 337.00 Mn |
| Mar 31, 2021 | 325.00 Mn |
| Dec 31, 2020 | 316.00 Mn |
| Sep 30, 2020 | 313.00 Mn |
| Mar 31, 2020 | 221.00 Mn |
| Dec 31, 2019 | 244.00 Mn |
| Sep 30, 2019 | 216.00 Mn |
| Mar 31, 2019 | 210.00 Mn |
| Dec 31, 2018 | 223.00 Mn |
| Jun 30, 2018 | 216.00 Mn |
| Mar 31, 2018 | 234.00 Mn |
| Dec 31, 2017 | 228.00 |
| Sep 30, 2017 | 222.00 |
| Jun 17, 2017 | 205.00 Mn |